Provisional Life Expectancy Estimates for January through June, 2020

Gee, Julianne; Marquez, Paige; Su, John; Calvert, Geoffrey M.; Liu, Ruiling; Myers, Tanya; Nair, Narayan; Martin, Stacey W.; Clark, Thomas; Markowitz, Lauri; Lindsey, Nicole; Zhang, Bicheng; Licata, Charles; Jazwa, Amelia; Sotir, Mark; Shimabukuro, Tom T.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Provisional Life Expectancy Estimates for January through June, 2020

February 19, 2021
By Gee, Julianne ; Marquez, Paige ; Su, John ; ...
Series: MMWR. Morbidity and mortality weekly report ; v. 70, early release, February 19, 2021

[PDF-161.04 KB]

English

Details Supporting Files You May Also Like

Details:

Personal Author:

Gee, Julianne ; Marquez, Paige ; Su, John ; Calvert, Geoffrey M. ; Liu, Ruiling ; ... More +

Gee, Julianne ; Marquez, Paige ; Su, John ; Calvert, Geoffrey M. ; Liu, Ruiling ; Myers, Tanya ; Nair, Narayan ; Martin, Stacey W. ; Clark, Thomas ; Markowitz, Lauri ; Lindsey, Nicole ; Zhang, Bicheng ; Licata, Charles ; Jazwa, Amelia ; Sotir, Mark ; Shimabukuro, Tom T. Less -
Corporate Authors:

CDC COVID-19 Response Team. ; United States. Food and Drug Administration.

CDC COVID-19 Response Team. ; United States. Food and Drug Administration. Less -
Description:

What is already known about this topic? Two COVID-19 vaccines have received Emergency Use Authorization for administration in the United States. In preauthorization clinical trials, local and systemic reactions were reported; no serious safety problems were detected.

What is added by this report? Monitoring, conducted as part of the U.S. vaccination program, indicates reassuring safety profiles for COVID-19 vaccines. Local and systemic reactions were common; rare reports of anaphylaxis were received. No unusual or unexpected reporting patterns were detected.

What are the implications for public health practice? Health care providers and vaccine recipients can be reassured about the safety of Pfizer BioNTech and Moderna COVID-19 vaccines. Counseling vaccine recipients to expect transient local and systemic reactions might ease concerns and encourage completion of the 2-dose vaccination series.

Suggested citation for this article: Gee J, Marquez P, Su J, et al. First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021. MMWR Morb Mortal Wkly Rep. ePub: 19 February 2021.

mm7008e3.htm?s_cid=mm7008e3_w

mm7008e3-H.pdf
Subjects:

[+]

Coronavirus Infections/prevention & Control COVID-19 Vaccines Patient Safety Viral Vaccines
Series:

MMWR. Morbidity and mortality weekly report ; v. 70, early release, February 19, 2021
Document Type:

Journal Article
Place as Subject:

United States
Pages in Document:

6 numbered pages
Volume:

70
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:4f13d061504c2a911003633d4506894dda7b0ac1a629767042d9fad6ec2e9660
Download URL:

https://stacks.cdc.gov/view/cdc/103109/cdc_103109_DS1.pdf
File Type:

mm7008e3.htm

htm

More +